{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:39:58Z","timestamp":1782959998671,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001530","name":"Canterbury Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.peptides.2019.170192","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T12:37:59Z","timestamp":1573216679000},"page":"170192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Cardiovascular effects of DWORF (dwarf open reading frame) peptide in normal and ischaemia\/reperfused isolated rat hearts"],"prefix":"10.1016","volume":"124","author":[{"given":"Prisca","family":"Mbikou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam T.","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Pemberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2019.170192_bib0005","series-title":"Cardiovascular Diseases","author":"World Health Organization","year":"2017"},{"issue":"18","key":"10.1016\/j.peptides.2019.170192_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: the Rotterdam Study","volume":"25","author":"Bleumink","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.peptides.2019.170192_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.12.018","article-title":"Cardiac SERCA2A\/B: therapeutic targets for heart failure","volume":"724","author":"Shareef","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"6270","key":"10.1016\/j.peptides.2019.170192_bib0020","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad4076","article-title":"A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.peptides.2019.170192_bib0025","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38319","article-title":"The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy","volume":"7","author":"Makarewich","year":"2018","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.peptides.2019.170192_bib0030","doi-asserted-by":"crossref","first-page":"H1522","DOI":"10.1152\/ajpheart.00193.2004","article-title":"Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion","volume":"287","author":"Pemberton","year":"2004","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"9","key":"10.1016\/j.peptides.2019.170192_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.0000176193.83629.c8","article-title":"Rho-kinase is an important therapeutic target in cardiovascular medicine","volume":"25","author":"Shimokawa","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.peptides.2019.170192_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/0735-1097(88)90451-2","article-title":"Prevention of coronary vasoconstriction by diltiazem during dynamic exercise in patients with coronary artery disease","volume":"12","author":"Nonogi","year":"1988","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.peptides.2019.170192_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40119-016-0059-1","article-title":"Clinical experience with diltiazem in the treatment of cardiovascular diseases","volume":"5","author":"Rodriguez Padial","year":"2016","journal-title":"Cardiol. Ther."},{"issue":"4","key":"10.1016\/j.peptides.2019.170192_bib0050","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0b013e3182a3718f","article-title":"Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil","volume":"62","author":"Shi","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2 Pt 2","key":"10.1016\/j.peptides.2019.170192_bib0055","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1093\/ajh\/4.2.185S","article-title":"Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium","volume":"4","author":"Schwinger","year":"1991","journal-title":"Am. J. Hypertens."},{"issue":"3 Pt 2","key":"10.1016\/j.peptides.2019.170192_bib0060","first-page":"II42","article-title":"Side effects of calcium channel blockers","volume":"11","author":"Russell","year":"1988","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.peptides.2019.170192_bib0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.peptides.2019.170192_bib0070","doi-asserted-by":"crossref","DOI":"10.1253\/circj.CJ-09-0462","article-title":"Overexpression of myosin phosphatase reduces Ca(2+) sensitivity of contraction and impairs cardiac function","volume":"74","author":"Mizutani","year":"2010","journal-title":"Circ. J."},{"issue":"6","key":"10.1016\/j.peptides.2019.170192_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039269","article-title":"Dynamic regulation of myosin light chain phosphorylation by Rho-kinase","volume":"7","author":"Kaneko-Kawano","year":"2012","journal-title":"PLoS One"},{"issue":"6654","key":"10.1016\/j.peptides.2019.170192_bib0080","doi-asserted-by":"crossref","DOI":"10.1038\/40187","article-title":"Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension","volume":"389","author":"Uehata","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.peptides.2019.170192_bib0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1476-5381.1985.tb08830.x","article-title":"Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells","volume":"85","author":"Barry","year":"1985","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.peptides.2019.170192_bib0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/CBB:46:3:233","article-title":"Theoretical and experimental investigation of calcium-contraction coupling in airway smooth muscle","volume":"46","author":"Mbikou","year":"2006","journal-title":"Cell Biochem. Biophys."},{"issue":"3-4","key":"10.1016\/j.peptides.2019.170192_bib0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10741-007-9026-1","article-title":"Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection","volume":"12","author":"Hausenloy","year":"2007","journal-title":"Heart Fail. Rev."},{"issue":"2","key":"10.1016\/j.peptides.2019.170192_bib0100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cardiores.2006.01.017","article-title":"Survival kinases in ischemic preconditioning and postconditioning","volume":"70","author":"Hausenloy","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.peptides.2019.170192_bib0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00395-007-0664-1","article-title":"Postconditioning protects human atrial muscle through the activation of the RISK pathway","volume":"102","author":"Sivaraman","year":"2007","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.peptides.2019.170192_bib0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yjmcc.2009.03.019","article-title":"Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?","volume":"47","author":"Lecour","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.peptides.2019.170192_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvp274","article-title":"Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway","volume":"84","author":"Lacerda","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.peptides.2019.170192_bib0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cvr\/cvp298","article-title":"No risk, no \u2026 cardioprotection? A critical perspective","volume":"84","author":"Heusch","year":"2009","journal-title":"Cardiovasc. Res."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:24:41Z","timestamp":1759310681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119301706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":24,"alternative-id":["S0196978119301706"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170192","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular effects of DWORF (dwarf open reading frame) peptide in normal and ischaemia\/reperfused isolated rat hearts","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170192"}}